Projects per year
Abstract
BACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multifactorial disease with an unexplained aetiology in which viral infections are possible trigger factors. The aim of this study was to determine the involvement of human herpesvirus (HHV)-6A/B, HHV-7, and parvovirus B19 (B19V) in the etiopathogenesis of ME/CFS.
METHODS: 200 patients with clinically diagnosed ME/CFS and 150 apparently healthy individuals were enrolled in this study. Single-round, nested, and quantitative real-time polymerase chain reactions (PCR) were used to detect the presence and load of HHV-6A/B, HHV-7, and B19V. HHV-6A and HHV-6B were distinguished by PCR and restriction analysis. Immunoenzymatic assays were applied to estimate the presence of virus-specific antibodies and the level of cytokines.
RESULTS: HHV-6A/B, HHV-7, and B19V specific antibodies were detected among patients and healthy individuals in 92.1% and 76.7%, 84.6% and 93.8%, and 78% and 67.4% of cases. HHV-6B had 99% of HHV-6 positive patients. Latent HHV-6A/B, HHV-7, and B19V infection/co-infection was observed in 51.5% of the patients and 76.7% of the healthy individuals, whereas active-45% of the ME/CFS patients and 8.7% of healthy individuals. HHV-6A/B load in patients with a persistent infection/co-infection in a latent and active phase was 262 and 653.2 copies/106 cells, whereas HHV-7 load was 166.5 and 248.5 copies/106 cells, and B19V-96.8 and 250.8 copies/106 cells, respectively. ME/CFS patients with persistent infection in an active phase had a higher level of pro-inflammatory cytokines (interleukin(IL)-6, tumor necrosis factor-alpha(TNF-α) and IL-12) and anti-inflammatory (IL-10) than with a persistent infection in a latent phase. A significant difference was revealed in the levels of TNF-α, IL-12, and IL-10 among the patient groups without infection, with latent infection/co-infection, active single, double and triple co-infection. The levels of TNF-α, IL-12, and IL-10 are significantly higher in patients with severe compared with a moderate course of ME/CFS.
CONCLUSIONS: Significantly more persistent HHV-6A/B, HHV-7, and B19V infection/co-infection in an active phase with a higher viral load and elevated levels of pro- and anti-inflammatory cytokines among patients with ME/CFS than healthy individuals indicate the importance of these infections/co-infections in ME/CFS development. The presence of these infections/co-infections influences the ME/CFS clinical course severity.
Original language | English |
---|---|
Article number | 33 |
Pages (from-to) | 33 |
Number of pages | 1 |
Journal | Journal of Translational Medicine |
Volume | 21 |
Issue number | 1 |
DOIs | |
Publication status | Published - 18 Jan 2023 |
Keywords*
- Humans
- Fatigue Syndrome, Chronic
- Interleukin-10
- Coinfection
- Tumor Necrosis Factor-alpha
- Persistent Infection
- Virus Diseases
- Cytokines
- Interleukin-12
- Myalgic encephalomyelitis/chronic fatigue syndrome,
- HHV-6B
- HHV-7
- HHV-6A
- Human parvovirus B19
Field of Science*
- 3.2 Clinical medicine
- 3.1 Basic medicine
Publication Type*
- 1.1. Scientific article indexed in Web of Science and/or Scopus database
Fingerprint
Dive into the research topics of 'The persistent viral infections in the development and severity of myalgic encephalomyelitis/chronic fatigue syndrome'. Together they form a unique fingerprint.Projects
- 1 Finished
-
VirA: Reducing networking gaps between Rīga Stradiņš University (RSU) and internationally - leading counterparts in viral infection-induced autoimmunity research
Murovska, M. (Project leader), Lunga, A. (Work package leader), Doniņa, S. (Work package leader), Nora-Krūkle, Z. (Work package leader), Groma, V. (Work package leader), Krūmiņa, A. (Work package leader), Rasa-Dzelzkalēja, S. (Work package leader), Holodņuka, I. (Participant), Skuja, S. (Leading expert) & Lejnieks, A. (Other)
1/12/20 → 30/11/23
Project: EU Programmes › Horizon 2020